glp 1 agonists moa Frontiers Mechanisms of action of GLP-1RA.
Description
Currently, it is only FDA-approved for the treatment of type 2 diabetes, but is being studied for the treatment of obesity, as it was seen to cause significant weight loss
The exposure groups were well balanced across all covariates, with no standardised difference above 0.02
D.IshikawaM.LeeB
J Alzheimers Dis
